BRIEF-Abarca, Amgen Enter Outcomes-Based Agreement For Repatha
February 22, 2018 at 12:32 PM EST
* ABARCA SAYS SIGNED OUTCOMES-BASED CONTRACT WITH AMGEN FOR CHOLESTEROL-LOWERING DRUG, REPATHA Source text for Eikon: Further company coverage:
